Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-19-000005

Options or other derivatives

  • Chief Science/Medical Officer acquired 184,659 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STRAYER DAVID R · Chief Science/Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-01-28 Grant or award : show line 1 in the form Options to buy Common Stock +184,659 184,659 D
Loading xslF345X03/primary_doc.xml…